Burkina Faso’s government has officially ended all activities linked to the controversial Target Malaria project, bringing more than a decade of genetically modified mosquito research in the country to an abrupt halt.
The decision, announced under the administration of President Ibrahim Traoré, ordered the closure of laboratories connected to the project and the destruction of all remaining genetically modified mosquito samples under official supervision.
Authorities also confirmed that all facilities associated with the initiative had been sealed as part of the shutdown.
Government Moves After Rising Public Opposition
The project had operated in Burkina Faso since 2012 and recently received regulatory approval for additional testing phases from the country’s biosafety authorities.
However, the initiative became increasingly controversial after growing public criticism and national debate over the release of genetically modified mosquitoes into the environment.
Critics argued that the people of Burkina Faso had not fully consented to their country becoming a testing ground for foreign biotechnology experiments. Concerns were also raised about possible environmental consequences, long-term ecological risks, and national sovereignty over scientific research.
The government ultimately decided to suspend all activities linked to the project, describing the move as necessary to protect public interest and scientific independence.
What Was the Target Malaria Project?
Target Malaria is an international scientific initiative focused on reducing malaria transmission through genetically modified mosquitoes designed to reduce mosquito reproduction rates.
Researchers involved in the project believed the technology could help fight malaria, one of Africa’s deadliest diseases, which continues to affect millions of people every year.
The initiative carried out research and controlled mosquito releases in selected communities as part of broader efforts to study the effectiveness of genetic mosquito control methods.
Who Funded and Managed the Project?
The Target Malaria project was primarily funded by the Bill & Melinda Gates Foundation, with additional support from Open Philanthropy and other international research partners.
The initiative was coordinated through an international consortium led by researchers connected to Imperial College London and involved scientific institutions from multiple countries, including the United States, the United Kingdom, Italy, Uganda, and Burkina Faso.
Supporters of the project described it as an innovative scientific effort aimed at reducing malaria-related deaths across Africa. However, opponents questioned whether foreign-backed biotechnology programs were being introduced with enough transparency and local public approval.
Laboratories Shut Down and Samples Ordered Destroyed
Government authorities confirmed that:
- All laboratories connected to the project were sealed
- Remaining genetically modified mosquito samples would be destroyed
- Nationwide project operations had been terminated
- Technical teams would oversee the disposal process
- The move officially ends Burkina Faso’s participation in one of the continent’s most closely watched biotechnology research programs.
International Debate Continues
The shutdown has sparked mixed reactions across Africa and internationally.
Supporters of genetic mosquito research argue that new technologies could help reduce the devastating impact of malaria across the continent. Critics, however, welcomed Burkina Faso’s decision, saying governments should exercise caution before approving large-scale biotechnology experiments involving genetically modified organisms.
The controversy has also fueled broader discussions about scientific sovereignty, environmental ethics, foreign-funded research, and public trust in emerging technologies.